Skip to main content
SpringerLink
Log in

Sandostatin Impairs Postresection Intestinal Adaptation in a Rat Model of Short Bowel Syndrome

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Because of its antisecretory properties, sandostatin has been advocated for the treatment of patients with short bowel syndrome (SBS). This study was conducted to determine the effect of sandostatin on structural intestinal adaptation, cell proliferation and apoptosis in a rat model of SBS. Sprague-Dawley rats were divided into three experimental groups: Sham rats underwent bowel transection, SBS rats underwent 75% small bowel resection, and SBS-sandostatin rats underwent bowel resection and were treated with sandostatin (SBS-SND). Parameters of intestinal adaptation, enterocyte proliferation, and enterocyte apoptosis were determined on day 14 following operation. We have demonstrated that SBS-SND animals demonstrated lower (vs SBS rats) duodenal and jejunal bowel weights, jejunal and ileal mucosal weight, jejunal and ileal mucosal DNA and protein, jejunal and ileal villus height, cell proliferation index in the ileum, and enterocyte apoptosis in jejunum and ileum. We conclude that in a rat model of SBS sandostatin decreases cell proliferation and inhibits structural intestinal adaptation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Booth IW, Lander AD: Short bowel syndrome. Bailliere's Clin Gastroenterol 12:739–772, 1998

    Google Scholar 

  2. Coran AG, Spivak D, Teitelbaum DH: An analysis of the morbidity and mortality of short bowel syndrome in the pediatric age group. Eur J Pediatr Surg 9:228–230, 1999

    Google Scholar 

  3. Schwartz MZ, Kuenzler KA: Pharmacotherapy and growth factors in the treatment of short bowel syndrome. Semin Pediatr Surg 10:81–90, 2001

    Google Scholar 

  4. Hodin RA, Salinger P, Meng S: Small bowel adaptation: counterregulatory effects of epidermal growth factor and somatostatin on the program of early gene expression. Surgery 118:206–211, 1995

    Google Scholar 

  5. Vanderhoof JA, Kollman KA: Lack of inhibitory effect of octreotide on intestinal adaptation in short bowel syndrome in the rat. J Pediatr Gastroenterol Nutr 26:241–244, 1997

    Google Scholar 

  6. Chomczynski P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques 15:532–536, 1993

    Google Scholar 

  7. Robinson MK, Ziegler TR, Wilmore DW: Overview of intestinal adaptation and its stimulation. Eur J Pediatr Surg 9:200–206, 1999

    Google Scholar 

  8. Hall PA, Coates PJ, Ansari B, Hopwood D: Regulation of cell number in the mammalian gastrointestinal tract: The importance of apoptosis. J Cell Sci 107:3569–3577, 1994

    Google Scholar 

  9. Lamers CBHW: Clinical and pathophysiological aspects of somatostatin and the gastrointestinal tract. Acta Endocrinol Suppl 286:19–25, 1987

    Google Scholar 

  10. Harris AG: Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. Gut Suppl 3:S1–S4, 1994

    Google Scholar 

  11. Arnold R, Simon B, Wied M: Treatment of neuroendocrine GEP tumours with somatostatin analogues: a review. Digestion Suppl 62:184–191, 2000

    Google Scholar 

  12. Tomassetti P, Migliori M, Corinaldesi R, Gullo L: Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR. Aliment Pharmacol Ther 14:557–560, 2000

    Google Scholar 

  13. Arnold R, Frank M: Gastrointestinal endocrine tumours: medical management. Baillieres Clin Gastroenterol 10:737–759, 1996

    Google Scholar 

  14. Beaugerie L, Baumer P, Chaussade S, Berard H, Rozenbaum W, Pialoux G, Le-Quintrec Y, Schwartz JC, Lecomte JM: Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study. Eur J Gastroenterol Hepatol 8:485–489, 1996

    Google Scholar 

  15. Li-Ling J, Irving M: Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials. Br J Surg 88:190–199, 2001

    Google Scholar 

  16. Dorta G: Role of octreotide and somatostatin in the treatment of intestinal fistulae. Digestion 60(suppl):253–256, 1999

    Google Scholar 

  17. Greenberg R, Haddad R, Kashtan H, Kaplan O: The effects of somatostatin and octreotide on experimental and human acute pancreatitis. J Lab Clin Med 135:112–121, 2000

    Google Scholar 

  18. Moloney M, Wilkinson M: Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Gastrointest Endosc 51:372–374, 2000

    Google Scholar 

  19. Dharmsathaphorn K, Gorelick FS, Sherwin RS, Cataland S, Dobbins JW: Somatostatin decreases diarrhea in patients with the short bowel syndrome. J Clin Gastroenterol 4:521–524, 1982

    Google Scholar 

  20. Nightingale JM, Walker ER, Burnham WR, Farthing MJ, Lennard-Jones JE: Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Ther 3:367–373, 1989

    Google Scholar 

  21. Ladefoged K, Christensen KC, Hegnhoj J, Jarnum S: Effect of a long acting somatostatin analogue SMS 201–995 on jejunostomy effluents in patients with severe short bowel syndrome. Gut 30:943–949, 1989

    Google Scholar 

  22. Rodrigues CA, Lennard-Jones JE, Thompson DG, Farthing MJ: The effects of octreotide, soy polysaccharide, codeine and loperamide on nutrient, fluid and electrolyte absorption in the short-bowel syndrome. Aliment Pharmacol Ther 3:159–169, 1989

    Google Scholar 

  23. Stange EF, Schneider A, Schusdziarra V, Ditschuneit H: Inhibitory effects of somatostatin on growth and differentiation in cultured intestinal mucosa. Horm Metab Res 16:74–78, 1984

    Google Scholar 

  24. Schneider A, Grosch G, Stange EF, Ditschuneit H. Influence of triamcinolone and somatostatin on morphometric parameters of cultured intestinal mucosa. In Vitro Cell Dev Biol 22:647–652, 1986

    Google Scholar 

  25. Bass BL, Fischer BA, Richardson C, Harmon JW: Somatostatin analogue treatment inhibits post-resectional adaptation of the small bowel in rats. Am J Surg 161:107–111, 1991

    Google Scholar 

  26. Thompson JS, Nguyen BLT, Harty RF: Somatostatin analogue inhibits intestinal regeneration. Arch Surg 128:385–389, 1993

    Google Scholar 

  27. Sagor GR, Ghatei MA, O'shaughnessy DJ, Al-Mukhtar MYT, Wright NA, Bloom SR: Influence of somatostatin and bomebesin on plasma enteroglucagon and cell proliferation after intestinal resection in the rat. Gut 26:89–94, 1985

    Google Scholar 

  28. Thompson JS: Epidermal growth factor inhibits somatostatin-induced apoptosis. J Surg Res 81:95–100, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rappaport Faculty of Medicine, Technion, Carmel Medical Center, Haifa, Israel

    Igor Sukhotnik, Kamal Khateeb, Edmund Sabo & Eitan Shiloni

  2. Rambam Medical Center, Haifa, Israel

    Michael M. Krausz

  3. Ha-Emek Medical Center, Afula, Israel

    Leonardo Siplovich & Arnold G. Coran

Authors
  1. Igor Sukhotnik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kamal Khateeb
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael M. Krausz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Edmund Sabo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Leonardo Siplovich
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Arnold G. Coran
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Eitan Shiloni
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sukhotnik, I., Khateeb, K., Krausz, M.M. et al. Sandostatin Impairs Postresection Intestinal Adaptation in a Rat Model of Short Bowel Syndrome. Dig Dis Sci 47, 2095–2102 (2002). https://doi.org/10.1023/A:1019641416671

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1019641416671

Search

Navigation